Citations (15)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Iacopo Chiodini, Daniela Merlotti, Alberto Falchetti & Luigi Gennari. (2020) Treatment options for glucocorticoid-induced osteoporosis. Expert Opinion on Pharmacotherapy 21:6, pages 721-732.
Read now
Read now
Articles from other publishers (14)
Riccardo Pofi, Giorgio Caratti, David W Ray & Jeremy W Tomlinson. (2023)
Treating the Side Effects of Exogenous Glucocorticoids; Can We Separate the
Good
From the
Bad
?
. Endocrine Reviews.
Crossref
Crossref
A. Libánská, E. Randárová, S. Skoroplyas, M. Bartoš, J. Luňáčková, F. Lager, G. Renault, D. Scherman & T. Etrych. (2023) Size-switchable polymer-based nanomedicines in the advanced therapy of rheumatoid arthritis. Journal of Controlled Release 353, pages 30-41.
Crossref
Crossref
Filippo Migliorini, Giorgia Colarossi, Jörg Eschweiler, Francesco Oliva, Arne Driessen & Nicola Maffulli. (2022) Antiresorptive treatments for corticosteroid-induced osteoporosis: a Bayesian network meta-analysis. British Medical Bulletin 143:1, pages 46-56.
Crossref
Crossref
Katherine D. Wysham, Joshua F. Baker & Radhika Narla. (2022) Osteoporosis evaluation and treatment recommendations in rheumatoid arthritis. Best Practice & Research Clinical Rheumatology 36:3, pages 101757.
Crossref
Crossref
Peter Oelzner, T. Eidner & A. Pfeil. (2022) Glukokortikoid-induzierte Osteoporose – Fokus Therapie (Teil 2)Glucocorticoid-induced osteoporosis—Focus treatment (part 2). Zeitschrift für Rheumatologie 81:2, pages 125-133.
Crossref
Crossref
Wenxiu Lai, Yulin Mo, Dongtao Wang, Ying Zhong, Lujiao Lu, Jiajia Wang, Liao Cui, Yanzhi Liu & Yajun Yang. (2021) Tanshinol Alleviates Microcirculation Disturbance and Impaired Bone Formation by Attenuating TXNIP Signaling in GIO Rats. Frontiers in Pharmacology 12.
Crossref
Crossref
Daniele Bellavia, Fabio Caradonna, Eufrosina Dimarco, Viviana Costa, Valeria Carina, Angela De Luca, Lavinia Raimondi, Milena Fini, Carla Gentile & Gianluca Giavaresi. (2021) Non-flavonoid polyphenols in osteoporosis: preclinical evidence. Trends in Endocrinology & Metabolism 32:7, pages 515-529.
Crossref
Crossref
Anett Vincze, János Gaál & Zoltán Griger. (2021) Bone Health in Idiopathic Inflammatory Myopathies: Diagnosis and Management. Current Rheumatology Reports 23:7.
Crossref
Crossref
Keiko MatsuiTadashi KawaiYushi EzoeToshiki YanagisawaTetsu TakahashiShinji Kamakura. (2021) Segmental Bone Reconstruction by Octacalcium Phosphate Collagen Composites with Teriparatide. Tissue Engineering Part A 27:9-10, pages 561-571.
Crossref
Crossref
Ikuko Tanaka, Yoshiya Tanaka, Satoshi Soen & Hisaji Oshima. (2020) Efficacy of once-weekly teriparatide in patients with glucocorticoid-induced osteoporosis: the TOWER-GO study. Journal of Bone and Mineral Metabolism 39:3, pages 446-455.
Crossref
Crossref
Loredana Iannella, Cristiana Colamonici, Davide Curcio, Francesco Botrè & Xavier de la Torre. (2020) Detecting the abuse of 19‐norsteroids in doping controls: A new gas chromatography coupled to isotope ratio mass spectrometry method for the analysis of 19‐norandrosterone and 19‐noretiocholanolone. Drug Testing and Analysis 13:4, pages 770-784.
Crossref
Crossref
Stefano Frara, Agnese Allora, Luigi di Filippo, Anna Maria Formenti, Paola Loli, Elisabetta Polizzi, Daniele Tradati, Fabio Massimo Ulivieri & Andrea Giustina. (2021) Osteopathy in mild adrenal Cushing’s syndrome and Cushing disease. Best Practice & Research Clinical Endocrinology & Metabolism 35:2, pages 101515.
Crossref
Crossref
Arnav Agarwal & Jonathan D. Adachi. (2021) Therapies for Preventing Bone Loss with Glucocorticoid Treatment. Current Osteoporosis Reports 19:1, pages 34-39.
Crossref
Crossref
Hilary Weidner, Victor Yuan Gao, Debra Dibert, Sean McTague, Mark Eskander, Randall Duncan, Liyun Wang & Anja Nohe. (2019) CK2.3, a Mimetic Peptide of the BMP Type I Receptor, Increases Activity in Osteoblasts over BMP2. International Journal of Molecular Sciences 20:23, pages 5877.
Crossref
Crossref